KRAS and neoplasm: Our study builds on these findings and establishes key differences between MMRd tumours of different aetiologies, with a triad of co-occurring somatic mutations in PTEN, PIKCA and KRAS being a common finding only in the sporadic MMRd tumours, implicating a reliance on MAPK and PI(3)K signalling.